AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+42.5%
5Y CAGR+31.0%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+42.5%/yr
vs +6.5%/yr prior
5Y CAGR
+31.0%/yr
Recent acceleration
Acceleration
+36.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$22.64B+15.0%
2024$19.68B+176.7%
2023$7.11B-9.0%
2022$7.82B-9.5%
2021$8.64B+47.0%
2020$5.88B+18.8%
2019$4.95B-18.5%
2018$6.07B-9.0%
2017$6.67B+23.0%
2016$5.43B-